Client News

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland – Company Provides Update on eAArly DETECT 2 Study

HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders

DEBRA Research and Nonsense Therapeutics Launch ReadOn Therapeutics to Accelerate Novel Therapies for Epidermolysis Bullosa

Mallia to Present sCD83’s Potential for Supporting Hair Transplantation at the FUE Europe Meeting in Madrid

Horus Pharma Becomes Additional Commercialization Partner for Formycon’s Eylea® Biosimilar FYB203 in Selected European Countries under the Brand Name Baiama®

Newron Presents H1 2025 Results and Provides Business Update  

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Lindis Blood Care Announces Publication of Final Results from Pivotal REMOVE Study with CATUVAB® in the Journal of Clinical Anesthesia

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review